Ausgabe 3/2020
Inhalt (24 Artikel)
Peri-operative chemotherapy for resectable colorectal lung metastasis: a systematic review and meta-analysis
Yuting Li, You Qin
Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis
Xin Liu, Kangming Lin, Xielin Huang, Wangkai Xie, Dan Xiang, Ning Ding, Changyuan Hu, Xian Shen, Xiangyang Xue, Yingpeng Huang
PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
Bastian Czogalla, Deborah Pham, Fabian Trillsch, Miriam Rottmann, Julia Gallwas, Alexander Burges, Sven Mahner, Thomas Kirchner, Udo Jeschke, Doris Mayr, Elisa Schmoeckel
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level
Qi Liu, Kuanyu Wang, Ruoyu Huang, Xuezhi Tong, Tao Jiang, Jiangfei Wang, Pei Yang
The PI3K pathway impacts stem gene expression in a set of glioblastoma cell lines
Eduardo Martinez, Neftali Vazquez, Alma Lopez, Victor Fanniel, Lilia Sanchez, Rebecca Marks, Leetoria Hinojosa, Victoria Cuello, Marisa Cuevas, Angelica Rodriguez, Cerin Tomson, Andrea Salinas, Mark Abad, Martin Holguin, Noel Garza, Abraham Arenas, Kevin Abraham, Luis Maldonado, Vivian Rojas, Alex Basdeo, Erin Schuenzel, Michael Persans, Wendy Innis-Whitehouse, Megan Keniry
New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
Ian A. MacNeil, David J. Burns, Benjamin E. Rich, Sajjad M. Soltani, Samantha Kharbush, Nicole G. Osterhaus, Brian F. Sullivan, Douglas M. Hawkins, Jodie R. Pietruska, Lance G. Laing
A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma
Lu Xing, Mingzhu Guo, Xiaoqi Zhang, Xiaoqian Zhang, Feng Liu
New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer
Huiping Qiang, Qing Chang, Jianlin Xu, Jialin Qian, Yanwei Zhang, Yuqiong Lei, Baohui Han, Tianqing Chu
Breast cancer: an update on treatment-related infertility
Erica Silvestris, Miriam Dellino, Paola Cafforio, Angelo Virgilio Paradiso, Gennaro Cormio, Stella D’Oronzo
Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma
Katharina Seystahl, Bettina Hentschel, Sarah Loew, Dorothee Gramatzki, Jörg Felsberg, Ulrich Herrlinger, Manfred Westphal, Gabriele Schackert, Niklas Thon, Marcos Tatagiba, Torsten Pietsch, Guido Reifenberger, Markus Löffler, Wolfgang Wick, Michael Weller
Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database
Steven Denyer, Abhiraj D. Bhimani, Shashank N. Patil, Andrew Mudreac, Mandana Behbahani, Ankit I. Mehta
Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy
Xun Shangguan, Hongyang Qian, Zhou Jiang, Zhixiang Xin, Jiahua Pan, Baijun Dong, Wei Xue
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Viola Heinzelmann-Schwarz, André B. Kind, Marcus Vetter, Kenneth Russell, Siti Omar, Andreas Schoetzau, Kerstin Hoeck, Daniel Fink, Michael L. Friedlander, Neville F. Hacker
A high serum-free fatty acid level is associated with cancer
Lili Zhang, Lei Han, Juan He, Jing Lv, Rongfang Pan, Teng Lv
Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus
Yuta Sekino, Toshiyuki Okumura, Nobuyoshi Fukumitsu, Takashi Iizumi, Haruko Numajiri, Masashi Mizumoto, Kei Nakai, Tetsuo Nonaka, Hitoshi Ishikawa, Hideyuki Sakurai
Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials
Jing Luo, Xinchi Dai, Hua Hu, Jie Chen, Lujun Zhao, Changyong Yang, Jifeng Sun, Lianmin Zhang, Qian Wang, Shilei Xu, Yue Xu, Ningbo Liu, Guoguang Ying, Ping Wang
Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer
Rui-Jia Sun, Lin Wang, Xiao-Ting Li, Qiao-Yuan Lu, Xiao-Yan Zhang, Zhen Guan, Ying-Shi Sun
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)
Annamaria Brioli, Kirsi Manz, Markus Pfirrmann, Mathias Hänel, Andreas Christoph Schwarzer, Gabriele Prange-Krex, Christian Fabisch, Stefan Knop, Thomas Illmer, Beate Krammer-Steiner, Andreas Hochhaus, Marie von Lilienfeld-Toal, Lars-Olof Mügge
Decision tree algorithm in locally advanced rectal cancer: an example of over-interpretation and misuse of a machine learning approach
Francesca De Felice, D. Crocetti, M. Parisi, V. Maiuri, E. Moscarelli, R. Caiazzo, N. Bulzonetti, D. Musio, V. Tombolini
Predictive models for patients with lung carcinomas to identify EGFR mutation status via an artificial neural network based on multiple clinical information
Xiaoyi Qin, Hailong Wang, Xiang Hu, Xiaolong Gu, Wei Zhou
The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
Rui Kitadai, Yusuke Okuma, Taiki Hakozaki, Yukio Hosomi
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
Lazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, Tobias Blau, Teresa Schmidt, Christoph Oster, Johannes Weller, Theophilos Tzaridis, Daniela Pierscianek, Kathy Keyvani, Christoph Kleinschnitz, Martin Stuschke, Björn Scheffler, Cornelius Deuschl, Ulrich Sure, Ulrich Herrlinger, Sied Kebir, Martin Glas
Combination of weekly streptozocin and oral S-1 treatment for patients of unresectable or metastatic pancreatic neuroendocrine neoplasms
Hiroaki Ono, Atsushi Kudo, Keiichi Akahoshi, Toshiro Ogura, Kosuke Ogawa, Daisuke Ban, Shinji Tanaka, Minoru Tanabe
Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients
Di-Han Liu, Zheng-Hao Ye, Si Chen, Xue-Song Sun, Jing-Yu Hou, Ze-Rui Zhao, Hao Long